Kom Op Tegen Kanker Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Belgium (1924)

Organization Overview

First Clinical Trial
2017
NCT03192059
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kom Op Tegen Kanker | Kom op tegen Kanker (Stand-up-to-Cancer), the Flemish cancer society